EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of a novel alloxan‐induced rabbit model exhibiting unique diabetic retinal neuropathy features assessed via ERG + VEP

Xinlu Li, Xiaojing Dong, Defei Feng, Han Hu, Bai Li, Zhongjian Liu, Wei He, Chenchen Huang, Zhizhou Shi, Yan Mei iD

Animal Models and Experimental Medicine · 2025

DOI: 10.1002/ame2.70032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Xinlu Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China. Hauptthemen laut MEDLINE: Evoked Potentials, Visual, Alloxan, Disease Models, Animal, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Project of Joint Special Funds for Applied Basic Research of Yunnan Provincial Department of Science and Technology Kunming Medical University, Clinical Research Center of the First People's Hospital of Yunnan Province, Kunming University of Science and Technology School of Medicine Postgraduate Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic retinal neuropathy (DRN) leads to significant visual impairment; however, no existing animal model fully replicates its neural alterations, and inconsistent induction protocols with high mortality rates hinder long‐term investigations.

Methods

Adult male rabbits were randomly assigned to four experimental groups, each receiving a single intravenous injection of varying doses of alloxan and one control group. The safety and efficacy of alloxan in inducing diabetes were evaluated to determine the optimal dose. At 9 weeks following injection with alloxan, retinal function was assessed using full‐field electroretinography (ERG) and visual evoked potentials (VEPs). Retinal structure was examined in rabbits using spectral‐domain optical coherence tomography (SD‐OCT), Optos ultra‐widefield (Optos UWF) false‐color imaging, and widefield fundus fluorescein angiography (WF‐FFA).

Results

Rabbits in the 80 mg/kg alloxan group exhibited fewer complications, lower mortality, and a higher model success rate compared to other groups. At 9 weeks post‐injection, these rabbits demonstrated significantly elevated hemoglobin A1c and total cholesterol ( p < 0.05) relative to controls. ERG revealed statistically significant reductions in oscillatory potential and b‐wave amplitudes ( p < 0.05), while VEP indicated decreased P2 amplitude ( p < 0.001) and prolonged P2 latency ( p < 0.05). SD‐OCT, Optos UWF imaging, and WF‐FFA demonstrated no significant changes in vascular abnormalities. Additionally, Hematoxylin and Eosin staining revealed retinal swelling ( p < 0.05), and immunofluorescence confirmed glial activation and neuronal loss.

Conclusions

A single intravenous injection of 80 mg/kg alloxan effectively and safely induced DRN in rabbits, resulting in neural retina damage, thereby establishing this model as an ideal model for DRN research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Evoked Potentials, VisualAlloxanDisease Models, AnimalDiabetes Mellitus, ExperimentalDiabetic RetinopathyDiabetic NeuropathiesAnimalsRabbitsElectroretinographyMaleTomography, Optical CoherenceRetina

Stichwörter der Autor:innen

ERG+opsVEPalloxandiabetic retinal neuropathyrabbit

Substanzen

Alloxan

Autor:innen und Institutionen

  • Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.
  • Department of Ophthalmology, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.
  • Department of Ophthalmology, The First People's Hospital of Yunnan Province, Kunming, China.
  • Medical School, Kunming University of Science and Technology, Kunming, China.
  • Center for Clinical Medicine Research, The First People's Hospital of Yunnan Province, Kunming, China.

ORCID-Profile: Yan Mei

Förderung

  • Key Project of Joint Special Funds for Applied Basic Research of Yunnan Provincial Department of Science and Technology Kunming Medical University
  • Clinical Research Center of the First People's Hospital of Yunnan Province
  • Kunming University of Science and Technology School of Medicine Postgraduate Innovation Fund
  • Research Plan of the National Natural Science Foundation of China
  • Provincial Key Clinical Specialty Platform of the First People's Hospital of Yunnan Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Dong, X., Feng, D., Hu, H., Li, B., Liu, Z., He, W., Huang, C., Shi, Z., & Mei, Y. (2025). Establishment of a novel alloxan‐induced rabbit model exhibiting unique diabetic retinal neuropathy features assessed via ERG + VEP. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70032

Vancouver

Li X, Dong X, Feng D, Hu H, Li B, Liu Z, et al. Establishment of a novel alloxan‐induced rabbit model exhibiting unique diabetic retinal neuropathy features assessed via ERG + VEP. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.70032

BibTeX
@article{Li2025,
  author = {Li, Xinlu and Dong, Xiaojing and Feng, Defei and Hu, Han and Li, Bai and Liu, Zhongjian and He, Wei and Huang, Chenchen and Shi, Zhizhou and Mei, Yan},
  title = {Establishment of a novel alloxan‐induced rabbit model exhibiting unique diabetic retinal neuropathy features assessed via ERG + VEP},
  journal = {Animal Models and Experimental Medicine},
  year = {2025},
  doi = {10.1002/ame2.70032}
}
Kostenlos starten →